BACKGROUND AND PURPOSE: In multiple sclerosis (MS), autologous hematopoietic stem cell transplantation (AHSCT) induces a profound suppression of clinical activity and MR imaging-detectable inflammation, but it may be associated with a rapid brain volume loss in the months subsequent to treatment. The aim of this study was to assess how AHSCT affects medium-term evolution of brain atrophy in MS. MATERIALS AND METHODS: MR imaging scans of the brain from 14 patients with rapidly evolving secondary-progressive MS obtained 3 months before and every year after AHSCT for 3 years were analyzed. Baseline normalized brain volumes and longitudinal percentage of brain volume changes (PBVCs) were assessed using the Structural Image Evaluation of Normalized Atrophy software. RESULTS: The median decrease of brain volume was 1.92% over the first year after AHSCT and then declined to 1.35% at the second year and to 0.69% at the third year. The number of enhancing lesions seen on the pretreatment scans was significantly correlated with the PBVCs between baseline and month 12 (r = -0.62; P = .02); no correlation was found with the PBVCs measured over the second and third years. CONCLUSIONS: After AHSCT, the rate of brain tissue loss in patients with MS declines dramatically after the first 2 years. The initial rapid development of brain atrophy may be a late consequence of the pretransplant disease activity and/or a transient result of the intense immunoablative conditioning procedure.
BACKGROUND AND PURPOSE: In multiple sclerosis (MS), autologous hematopoietic stem cell transplantation (AHSCT) induces a profound suppression of clinical activity and MR imaging-detectable inflammation, but it may be associated with a rapid brain volume loss in the months subsequent to treatment. The aim of this study was to assess how AHSCT affects medium-term evolution of brain atrophy in MS. MATERIALS AND METHODS: MR imaging scans of the brain from 14 patients with rapidly evolving secondary-progressive MS obtained 3 months before and every year after AHSCT for 3 years were analyzed. Baseline normalized brain volumes and longitudinal percentage of brain volume changes (PBVCs) were assessed using the Structural Image Evaluation of Normalized Atrophy software. RESULTS: The median decrease of brain volume was 1.92% over the first year after AHSCT and then declined to 1.35% at the second year and to 0.69% at the third year. The number of enhancing lesions seen on the pretreatment scans was significantly correlated with the PBVCs between baseline and month 12 (r = -0.62; P = .02); no correlation was found with the PBVCs measured over the second and third years. CONCLUSIONS: After AHSCT, the rate of brain tissue loss in patients with MS declines dramatically after the first 2 years. The initial rapid development of brain atrophy may be a late consequence of the pretransplant disease activity and/or a transient result of the intense immunoablative conditioning procedure.
Authors: A Saiz; Y Blanco; E Carreras; J Berenguer; M Rovira; T Pujol; P Marín; T Arbizu; F Graus Journal: Neurology Date: 2004-01-27 Impact factor: 9.910
Authors: Richard K Burt; Bruce Cohen; John Rose; Finn Petersen; Yu Oyama; Dusan Stefoski; George Katsamakis; Ewa Carrier; Tomas Kozak; Paolo A Muraro; Roland Martin; Roger Hintzen; Shimon Slavin; Dimitrios Karussis; Shalom Haggiag; Julio C Voltarelli; George W Ellison; Borko Jovanovic; Uday Popat; Joseph McGuirk; Laisvyde Statkute; Larissa Verda; Judith Haas; Renate Arnold Journal: Arch Neurol Date: 2005-06
Authors: M Peper; S Steinvorth; P Schraube; S Fruehauf; R Haas; B N Kimmig; F Lohr; F Wenz; M Wannenmacher Journal: Int J Radiat Oncol Biol Phys Date: 2000-01-15 Impact factor: 7.038
Authors: M Inglese; G L Mancardi; E Pagani; M A Rocca; A Murialdo; R Saccardi; G Comi; M Filippi Journal: J Neurol Neurosurg Psychiatry Date: 2004-04 Impact factor: 10.154
Authors: J-P Stellmann; K H Stürner; F Ufer; S Havemeister; J Pöttgen; F Ayuk Ayuketang; N Kröger; M A Friese; C Heesen Journal: Nervenarzt Date: 2015-08 Impact factor: 1.214
Authors: Min Seong Kwon; Seung Kyoon Woo; David B Kurland; Sung Hwan Yoon; Andre F Palmer; Uddyalok Banerjee; Sana Iqbal; Svetlana Ivanova; Volodymyr Gerzanich; J Marc Simard Journal: Int J Mol Sci Date: 2015-03-05 Impact factor: 5.923